comparemela.com

Latest Breaking News On - Swk holdings corporation - Page 7 : comparemela.com

SWK Holdings Provides Portfolio Update Highlighting Recent Achievements

/PRNewswire/ SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science focused specialty finance company catering to small- and.

United statesEnteris biopharmaRajiv khoslaEnteri peptelligenceTrio healthcare ltdMoleculight incIweb incKeystone dental incVeru incBioventus incVeru female health companyAcerus pharmaceuticalsHoldings portfolio updatesBiotricity incSolsys medicalEton pharmaceuticals

Special Committee Concludes Review of Non-Binding Proposal from Carlson Capital

/PRNewswire/ SWK Holdings Corporation (Nasdaq: SWKH) (the "Company" or "SWK") today announced that the special committee of the Company s board of directors.

United statesHoldings corporationHoldings corporation nasdaqCarlson capitalSpecial committeeSwk holdings corporation

Special Committee Concludes Review of Non-Binding Proposal from Carlson Capital

/PRNewswire/ SWK Holdings Corporation (Nasdaq: SWKH) (the "Company" or "SWK") today announced that the special committee of the Company s board of directors.

United statesHoldings corporationHoldings corporation nasdaqCarlson capitalSpecial committeeSwk holdings corporation

SWK Holdings Subsidiary, Enteris BioPharma, Receives $5 Million Milestone Payment from Cara Therapeutics

/PRNewswire/ SWK Holdings Corporation (Nasdaq: SWKH), a life sciences focused specialty finance company catering to small- and mid-sized commercial-stage.

United statesSouth koreaEnteris biopharmaRajiv khoslaEnteri peptelligenceExchange commissionHoldings corporationHoldings corporation nasdaqCara therapeuticsWinston blackTherapeutic oralPrivate securities litigation reform actSwk holdings corporation

SWK Holdings Subsidiary, Enteris BioPharma, Receives $5 Million Milestone Payment from Cara Therapeutics

/PRNewswire/ SWK Holdings Corporation (Nasdaq: SWKH), a life sciences focused specialty finance company catering to small- and mid-sized commercial-stage.

United statesSouth koreaEnteris biopharmaRajiv khoslaEnteri peptelligenceExchange commissionHoldings corporationHoldings corporation nasdaqCara therapeuticsWinston blackTherapeutic oralPrivate securities litigation reform actSwk holdings corporation

vimarsana © 2020. All Rights Reserved.